Table 1. Characteristics of Phlebotomized Only PV patients.
Patient | Age/gender | JAK -2 | WBC/Platelet (x109/ml) | Spleen (CM) | HX of Thrombosis | IGF-1R |
---|---|---|---|---|---|---|
1 | 73/M | 28.7%* | 12.3/756 | 11 | N | 38.08 |
2 | 78/M | positive | 10.0/430 | 11 | N | 323.8 |
3 | 70/F | positive | 9.0/425 | 11 | N | 35.2 |
4 | 72/M | positive | 11.2/450 | 11 | N | 461.7 |
5 | 71/F | positive | 9.0/433 | 11 | N | 324.9 |
6 | 72/M | 67% | 18.2/288 | 18 | N | 983 |
7 | 51/F | positive | 20.5/732 | 11 | N | 350 |
8 | 61/M | positive | 19.5/691 | 11 | N | 414 |
9 | 74/M | positive | 13.6/873 | 11 | Y | 505.9 |
10 | 69/F | 86% | 12.1/489 | 16 | N | 459.4 |
11 | 65/F | Negative** | 5.5/170 | 11 | N | 202 |
12 | 69/F | 91% | 29.5/896 | 16 | N | 353.5 |
13 | 70/F | 37% | 4.8/354 | 11 | N | 1082 |
14 | 69/F | 8% | 18.7/677 | 11 | N | 374.03 |
15 | 89/F | positive | 26/226 | 11 | N | 182 |
16 | 81/M | 20% | 13.0/153 | 11 | N | 369.5 |
* denotes percentage of allele-burden of JAK2V617F
** Diagnosis was made by the bone marrow and increased of RBC mass.